Literature DB >> 28229431

Hypertensive Disorders of Pregnancy.

Sahar Naderi1, Sandra A Tsai2, Abha Khandelwal3.   

Abstract

PURPOSE OF REVIEW: Although pregnancy-related deaths are rare in the USA, they are on the rise and have more than doubled in the last 20 years. A substantial portion of these deaths are related to cardiovascular disease, specifically hypertensive disorders of pregnancy (HDP). In this review, we will discuss the definitions and proposed pathophysiology of HDP as well as its potential role in cardiovascular morbidity and mortality. RECENT
FINDINGS: Placental hypoperfusion may lead to an imbalance in proangiogenic and antiangiogenic factors, notably an increase in soluble fms-like tyrosine kinsase-1 (sFlt-1), thereby leading to endothelial dysfunction. Progress has been made in terms of determining the factors which lead to preeclampsia. Potential novel biomarkers for predicting preeclampsia risk have been identified through this research. Preeclampsia not only has important implications for the health during pregnancy but also for future cardiovascular risk. However, the exact mechanism by which it increases cardiovascular risk and the degree of risk it portends are yet to be elucidated.

Entities:  

Keywords:  Gestational hypertension; Hypertensive disorders of pregnancy; Preeclampsia

Mesh:

Year:  2017        PMID: 28229431     DOI: 10.1007/s11883-017-0648-z

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  29 in total

1.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

Review 2.  Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question.

Authors:  S Ananth Karumanchi; Yuval Bdolah
Journal:  Endocrinology       Date:  2004-11       Impact factor: 4.736

3.  Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

Review 4.  Why is placentation abnormal in preeclampsia?

Authors:  Susan J Fisher
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

5.  Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness.

Authors:  S AbdAlla; H Lother; A el Massiery; U Quitterer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

6.  Abortion, changed paternity, and risk of preeclampsia in nulliparous women.

Authors:  Audrey F Saftlas; Richard J Levine; Mark A Klebanoff; Karen L Martz; Marian G Ewell; Cynthia D Morris; Baha M Sibai
Journal:  Am J Epidemiol       Date:  2003-06-15       Impact factor: 4.897

7.  Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Juan Pedro Kusanovic; Eleazar Soto; Jennifer Lam; Zhong Dong; Nandor G Than; Lami Yeo; Edgar Hernandez-Andrade; Agustín Conde-Agudelo; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

8.  Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004.

Authors:  Anne B Wallis; Audrey F Saftlas; Jason Hsia; Hani K Atrash
Journal:  Am J Hypertens       Date:  2008-03-13       Impact factor: 2.689

9.  Hypertensive disorders and severe obstetric morbidity in the United States.

Authors:  Elena V Kuklina; Carma Ayala; William M Callaghan
Journal:  Obstet Gynecol       Date:  2009-06       Impact factor: 7.661

10.  Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.

Authors:  Sarosh Rana; Camille E Powe; Saira Salahuddin; Stefan Verlohren; Frank H Perschel; Richard J Levine; Kee-Hak Lim; Julia B Wenger; Ravi Thadhani; S Ananth Karumanchi
Journal:  Circulation       Date:  2012-01-18       Impact factor: 29.690

View more
  16 in total

1.  Doppler ultrasound and photoplethysmographic assessment for identifying pregnancy-induced hypertension.

Authors:  Xiurong Sun; Fangming Su; Xuelin Chen; Qihui Peng; Xiaomin Luo; Xinghai Hao
Journal:  Exp Ther Med       Date:  2019-12-31       Impact factor: 2.447

2.  Association of Preconception Blood Pressure with the Risk of Anemia in Children under Five Years of Age: A Large Longitudinal Chinese Birth Cohort.

Authors:  Hang An; Huiting Chen; Zhiwen Li; Le Zhang; Yali Zhang; Jianmeng Liu; Rongwei Ye; Nan Li
Journal:  Nutrients       Date:  2022-06-26       Impact factor: 6.706

3.  The association of various obstetric and perinatal factors with retinopathy of prematurity.

Authors:  Ozlem Ozgur Gursoy; Hulusi Goktug Gurer; Ceren Yildiz Eren; Pinar Erdogan Ozgur; Huseyin Gursoy
Journal:  Int Ophthalmol       Date:  2022-03-29       Impact factor: 2.029

4.  The burden of hypertensive disorders of pregnancy in Africa: A systematic review and meta-analysis.

Authors:  Jean Jacques Noubiap; Jean Joel Bigna; Ulrich Flore Nyaga; Ahmadou M Jingi; Arnaud D Kaze; Jobert Richie Nansseu; Joël Fokom Domgue
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-03-07       Impact factor: 3.738

Review 5.  Environmental Toxicant Exposure and Hypertensive Disorders of Pregnancy: Recent Findings.

Authors:  Linda G Kahn; Leonardo Trasande
Journal:  Curr Hypertens Rep       Date:  2018-08-08       Impact factor: 4.592

Review 6.  Considering environmental exposures to per- and polyfluoroalkyl substances (PFAS) as risk factors for hypertensive disorders of pregnancy.

Authors:  Abigail Erinc; Melinda B Davis; Vasantha Padmanabhan; Elizabeth Langen; Jaclyn M Goodrich
Journal:  Environ Res       Date:  2021-04-03       Impact factor: 8.431

7.  Effect of gestational diabetes and hypertensive disorders of pregnancy on postpartum cardiometabolic risk.

Authors:  Ling-Jun Li; Izzuddin M Aris; Lin Lin Su; Yap Seng Chong; Tien Yin Wong; Kok Hian Tan; Jie Jin Wang
Journal:  Endocr Connect       Date:  2018-02-14       Impact factor: 3.335

8.  Excessive gestational weight gain in accordance with the IOM criteria and the risk of hypertensive disorders of pregnancy: a meta-analysis.

Authors:  Min Ren; Hanying Li; Wei Cai; Xiulong Niu; Wenjie Ji; Zhuoli Zhang; Jianmin Niu; Xin Zhou; Yuming Li
Journal:  BMC Pregnancy Childbirth       Date:  2018-07-04       Impact factor: 3.007

9.  Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women.

Authors:  Nadia M Ikumi; Thokozile R Malaba; Komala Pillay; Marta C Cohen; Hlengiwe P Madlala; Mushi Matjila; Dilly Anumba; Landon Myer; Marie-Louise Newell; Clive M Gray
Journal:  AIDS       Date:  2021-04-01       Impact factor: 4.177

10.  Metabolic disorders during pregnancy and postpartum cardiometabolic risk.

Authors:  Angelo Maria Patti; Kalliopi Pafili; Nikolaos Papanas; Manfredi Rizzo
Journal:  Endocr Connect       Date:  2018-04-30       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.